Child Study For Major Depressive Disorder
Posted Date: Nov 22, 2019
- Investigator: Jeffrey Strawn
- Specialties: Adolescent Psychiatry/Psychology, Depression
- Type of Study: Drug
A Double-blind, Placebo- and Active-Controlled Evaluation of the Safety and Efficacy of Levomilnacipran ER in Pediatric Patients 7-17 Years with Major Depressive Disorder
Criteria:
7 And 17 Years Of Age, Diagnosis Of Major Depressive Disorder,
Keywords:
Major Depressive Disorder, Depression
For More Information:
Heidi K. Schroeder, Bs
(513) 558-4422
heysehk@ucmail.uc.edu